Open AccessRole of Hormonal Receptor in Predicting Sentinel Lymph Node Metastasis in Early Breast Cancer
Author(s) -
Dedy Hermansyah,
Wahyu Indra,
Desiree Anggia Paramita,
Edwin Saleh Siregar
Publication year - 2022
Publication title -
medicinski arhiv
Language(s) - English
Resource type - Journals
eISSN - 1986-5961
pISSN - 0350-199X
DOI - 10.5455/medarh.2022.76.34-38
Subject(s) - sentinel lymph node , medicine , lymph , breast cancer , metastasis , lymph node , biopsy , sentinel node , oncology , hormonal therapy , hormone , cancer , radiology , pathology
Sentinel lymph node biopsy is one of the minimally invasive techniques that can confirm the presence of metastasis of regional lymph nodes in cancer. Sentinel lymph node biopsy can be done with a lymph mapping technique using blue-dye, radiotracer, or a combination of both. In developing countries, sentinel lymph node biopsy is often done with a single agent, which is the blue dye. The limitation of conducting SLNB in Indonesia is the availability of patent blue dye and radioisotope tracer. To overcome that, a hormonal receptor is expected to aid in predicting sentinel lymph node metastasis.